Retraction: Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas
Autor: | Velidi H. Rao, Chrissa Sioka, Meena Gujrati, Christopher S. Gondi, Dzung H. Dinh, William C. Olivero, Sajani S. Lakka, Jasti S. Rao |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
Time Factors Angiogenesis Interference (genetic) Biochemistry Mice Gene expression Withdrawals/Retractions Phosphorylation RNA Small Interfering Receptor Extracellular Signal-Regulated MAP Kinases Promoter Regions Genetic Cell Line Transformed Neovascularization Pathologic Chemistry Brain Neoplasms Matrix metalloproteinase 9 Glioma Immunohistochemistry Drug Combinations Matrix Metalloproteinase 9 Female Proteoglycans RNA Interference Collagen medicine.drug MAP Kinase Signaling System Genetic Vectors Green Fluorescent Proteins Down-Regulation Mice Nude Receptors Cell Surface Transfection Models Biological Gene Expression Regulation Enzymologic Receptors Urokinase Plasminogen Activator Cell Line Tumor medicine Animals Humans Tumor growth Neoplasm Invasiveness Gene Silencing Molecular Biology Cell Proliferation RNA Double-Stranded Urokinase Models Genetic Cell Biology Protein Structure Tertiary Cancer research Nucleic Acid Conformation Laminin Glioblastoma Plasminogen activator |
Zdroj: | J Biol Chem |
Popis: | We have previously demonstrated the effectiveness of adenovirus-mediated expression of antisense urokinase-type plasminogen activator receptor (uPAR) and matrix metalloproteinase-9 (MMP-9) in inhibiting tumor invasion in vitro and ex vivo. However, the therapeutic effect of the adenovirus-mediated antisense approach was shown to be transient and required potentially toxic, high viral doses. In contrast, RNA interference (RNAi)-mediated gene targeting may be superior to the traditional antisense approach, because the target mRNA is completely degraded and the molar ratio of siRNA required to degrade the target mRNA is very low. Here, we have examined the siRNA-mediated target RNA degradation of uPAR and MMP-9 in human glioma cell lines. Using RNAi directed toward uPAR and MMP-9, we achieved specific inhibition of uPAR and MMP-9. This bicistronic construct (pUM) inhibited the formation of capillary-like structures in both in vitro and in vivo models of angiogenesis. We demonstrated that blocking the expression of these genes results in significant inhibition of glioma tumor invasion in Matrigel and spheroid invasion assay models. RNAi for uPAR and MMP-9 inhibited cell proliferation, and significantly reduced the levels of phosphorylated forms of MAPK, ERK, and AKT signaling pathway molecules when compared with parental and empty vector/scrambled vector-transfected SNB19 cells. Furthermore, using RNAi to simultaneously target two proteases resulted in total regression of pre-established intracerebral tumor growth. Our results provide evidence that the use of hairpin siRNA expression vectors for uPAR and MMP-9 may provide an effective tool for cancer therapy. |
Databáze: | OpenAIRE |
Externí odkaz: |